Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Vitamin K for Warfarin Associated Coagulopathy
This study has been completed.
Study NCT00143715   Information provided by St. Joseph's Healthcare
First Received: August 31, 2005   Last Updated: December 2, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coagulation
Bleeding
Thrombosis
Additional conditions recognized in this trial
Blood Coagulation Disorders
Hemostatic Disorders
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Hematologic Diseases
Hemorrhagic Disorders
Vascular Diseases
Interventions listed in this trial
Phytonadione (Vitamin K1)
Additional drug interventions recognized in this trial
Vitamin K
Vitamin K 1
Vitamins
Warfarin
More general drug interventions related to this trial
Anticoagulants
Antifibrinolytic Agents
Coagulants
Fibrin Modulating Agents
Growth Substances
Hematologic Agents
Hemostatics
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
St. Joseph's Healthcare
McMaster University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services